Heritage Investors Management Corp Has $9.84 Million Stake in McKesson Co. (MCK)
Heritage Investors Management Corp raised its stake in McKesson Co. (NYSE:MCK) by 8.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,173 shares of the company’s stock after purchasing an additional 5,685 shares during the quarter. Heritage Investors Management Corp’s holdings in McKesson were worth $9,839,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Boston Partners increased its position in shares of McKesson by 54.5% during the second quarter. Boston Partners now owns 6,237,042 shares of the company’s stock valued at $832,021,000 after acquiring an additional 2,200,669 shares during the last quarter. Vulcan Value Partners LLC increased its position in shares of McKesson by 7.8% during the second quarter. Vulcan Value Partners LLC now owns 3,768,099 shares of the company’s stock valued at $502,664,000 after acquiring an additional 273,090 shares during the last quarter. Pzena Investment Management LLC increased its position in shares of McKesson by 7.6% during the second quarter. Pzena Investment Management LLC now owns 2,836,710 shares of the company’s stock valued at $378,417,000 after acquiring an additional 201,062 shares during the last quarter. American Century Companies Inc. increased its position in shares of McKesson by 13.6% during the third quarter. American Century Companies Inc. now owns 1,735,496 shares of the company’s stock valued at $230,214,000 after acquiring an additional 207,533 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of McKesson by 3.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,424,630 shares of the company’s stock valued at $190,107,000 after acquiring an additional 46,386 shares during the last quarter. 89.19% of the stock is owned by hedge funds and other institutional investors.
In other McKesson news, Director N Anthony Coles sold 1,350 shares of the stock in a transaction on Friday, August 31st. The stock was sold at an average price of $128.69, for a total transaction of $173,731.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.87% of the stock is currently owned by corporate insiders.
Shares of NYSE MCK opened at $130.81 on Friday. McKesson Co. has a 1-year low of $117.19 and a 1-year high of $178.86. The firm has a market cap of $25.93 billion, a price-to-earnings ratio of 9.90, a PEG ratio of 1.51 and a beta of 1.05. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.56.
McKesson (NYSE:MCK) last announced its quarterly earnings data on Thursday, October 25th. The company reported $3.60 earnings per share for the quarter, beating the consensus estimate of $3.28 by $0.32. McKesson had a return on equity of 26.55% and a net margin of 0.06%. The business had revenue of $53.08 billion during the quarter, compared to analyst estimates of $53.56 billion. Analysts anticipate that McKesson Co. will post 13.41 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 2nd. Shareholders of record on Monday, December 3rd will be issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 1.19%. The ex-dividend date is Friday, November 30th. McKesson’s dividend payout ratio (DPR) is 12.36%.
TRADEMARK VIOLATION WARNING: This story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2018/11/10/heritage-investors-management-corp-has-9-84-million-stake-in-mckesson-co-mck.html.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Recommended Story: Hedge Funds – How They Work For Investors
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.